Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Docetaxel-loaded pH/ROS dual-responsive nanoparticles for the targeted treatment of gastric cancer

Fig. 4

Influence of DTX and its nanoformulations on cell cycle distribution of HGC-27 cells. A Flow cytometry images of the HGC-27 cell cycle after DTX or DTX nanoformulations treatment. B Proportions of HGC-27 cells in each cell cycle stage shown in A. C Western blot analysis of the TUBB3 protein in HGC-27 cells subjected to different treatments. D Semiquantitative analysis of TUBB3 protein expression in HGC-27 cells subjected to various treatments. *, significantly different at p < 0.05; **, significantly different at p < 0.01; ***, significantly different at p < 0.001

Back to article page